scholarly article | Q13442814 |
P356 | DOI | 10.1177/0961203309361353 |
P698 | PubMed publication ID | 20353979 |
P50 | author | Ricard Cervera i Segura | Q53547424 |
P2093 | author name string | CAPS Registry Project Group | |
P2860 | cites work | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 |
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies | Q33360771 | ||
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients | Q33366327 | ||
Relapsing catastrophic antiphospholipid syndrome: report of three cases | Q33377259 | ||
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients | Q33502956 | ||
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients | Q34435380 | ||
Long term outcome of catastrophic antiphospholipid syndrome survivors | Q35552789 | ||
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome | Q35555909 | ||
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients | Q35636571 | ||
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". | Q44550364 | ||
Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients | Q56907610 | ||
P433 | issue | 4 | |
P921 | main subject | catastrophic antiphospholipid syndrome | Q5051580 |
P304 | page(s) | 412-418 | |
P577 | publication date | 2010-04-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'. | |
P478 | volume | 19 |
Q53245134 | A 26-year-old white man with a systemic lupus erythematosus flare and acute multiorgan ischemia: Vasculitis or thrombosis? |
Q37853593 | An approach to the patient with retiform purpura |
Q55891386 | Antiphospholipid syndrome |
Q64046338 | Antiphospholipid syndrome |
Q37820338 | Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach |
Q53758664 | Catastrophic Antiphospholipid Syndrome. |
Q88012285 | Catastrophic antiphospholipid syndrome presenting with pulmonary hemorrhage: case report |
Q26825077 | Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease |
Q47705914 | European Forum On Antiphospholipid Antibodies: brief history report and governance document |
Q38826804 | Immunotherapeutic strategies in antiphospholipid syndrome |
Q92464625 | Perioperative medical management for patients with RA, SPA, and SLE undergoing total hip and total knee replacement: a narrative review |
Q38359475 | Postoperative risk of venous thromboembolism in rheumatic disease patients |
Q53134970 | Probable catastrophic antiphospholipid syndrome complicated with primary sclerosing cholangitis. |
Q33401365 | Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy |
Q33692770 | Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety |
Q53159273 | Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. |
Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
Q40188862 | The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome |
Q48509173 | The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome |
Q42123111 | The flare up of catastrophic antiphospholipid syndrome: a report of an immunosuppressive withdrawal-induced case. |
Q33420910 | The significance and management of thrombocytopenia in antiphospholipid syndrome |
Q33411317 | Thrombocytopenia and thrombosis: a double-edged sword |
Q37809779 | Update on Antiphospholipid Syndrome in Children |
Search more.